Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 203
Ph III recruiting: 21
Growth YoY: +3.8%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06726291	Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer(NOEME)	recruiting	Phase 4	84	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER	1	Dec 10, 2024	clinicaltrials
NCT02543710	Biomarker Guided Treatment in Gynaecological Cancer(Momatec2)	recruiting	Phase 4	1,300	Haukeland University HospitalOTHER	3	Mar 28, 2017